✦ LIBER ✦

1207 High-dose peginterferon alfa-2A (40KD) (PEGASYS) and ribavirin (COPEGUS) in patients infected with hepatitis C virus (HCV) genotype 1 who failed to respond to interferon alfa and ribavirin

✍ Scribed by DIAGO, M; ROMEROGOMEZ, M; DEVALME, H; CRESPO, J; VALDECILLA, H; OLVEIRA, A; LAPAZ, H; PEREZ, R; BARCENA, R; SANCHEZTAPIAS, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

566 Pharmacokinetics and pharmacodynamic

✍ M. Diago; M. Romero-Gomez; J. Crespo; A. Olveira; R. Perez; R. Barcena; J.M. San 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 265 KB

187 Efficacy and safety of 22 weeks of m

✍ Jean-Pierre Bronowicki; Denis Ouzan; Arnaud Tzanck; Tarik Asselah; Herve Desmora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

328 Comparison of 48 or 72 weeks of trea

✍ Thomas Berg; M. Von Wagner; H. Hinrichsen; T. Heintges; P. Buggisch; T. Goeser; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

332 Peginterferon alfa-2A (40KD) (PEGASY

✍ Charles Howell; Lennox S. Jeffers; William Cassidy; K. Rajender Reddy; Susan She 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

995 A dynamic model to predict sustained

✍ FERENCI, P; FRIED, M; CHANEAC, M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

307 Peginterferon alfa-2A (40KD) (PEGASY

✍ William Cassidy; Lennox S. Jeffers; Charles Howell; K. Rajender Reddy; Susan She 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB